国: アイルランド
言語: 英語
ソース: HPRA (Health Products Regulatory Authority)
ICODEXTRIN ; SODIUM CHLORIDE ; SODIUM LACTATE ; CALCIUM CHLORIDE DIHYDRATE ; MAGNESIUM CHLORIDE ANHYDROUS
Baxter Healthcare Limited
B05DA
ICODEXTRIN ; SODIUM CHLORIDE ; SODIUM LACTATE ; CALCIUM CHLORIDE DIHYDRATE ; MAGNESIUM CHLORIDE ANHYDROUS
N/A
Solution for Dialysis
Product subject to prescription which may not be renewed (A)
Isotonic solutions
Marketed
1997-07-25
CB-30-02-186 1 PACKAGE LEAFLET: INFORMATION FOR THE USER EXTRANEAL Solution for Peritoneal Dialysis Read all of this leaflet carefully before you start using this medicine. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor. – If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What EXTRANEAL is and what it is used for 2. What you need to know before you use EXTRANEAL 3. How to use EXTRANEAL 4. Possible side effects 5. How to store EXTRANEAL 6. Contents of the pack and other information 1. WHAT EXTRANEAL IS AND WHAT IT IS USED FOR EXTRANEAL is a solution for peritoneal dialysis. The peritoneal cavity is the cavity in your abdomen (belly) between your skin and the peritoneum. The peritoneum is the membrane surrounding your internal organs such as your intestines and liver. The EXTRANEAL solution is placed into the peritoneal cavity where it removes water and waste products from the blood. It also corrects abnormal levels of different blood components. EXTRANEAL may be prescribed for you if: • You are an adult with permanent kidney failure which needs peritoneal dialysis. • Standard glucose peritoneal dialysis solutions alone cannot remove sufficient water. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE EXTRANEAL Your doctor must supervise you the first time you use this product. Do NOT use EXTRANEAL • if you are allergic to icodextrin or starch derivatives (e.g. maize starch) or any of the other ingredients of EXTRANEAL • if you are intolerant to maltose or isomaltose (sugar coming from starch) • if you have glycogen storage disease • if you already have severe lactic acidosis (too much acid in the blood) • if you have a surgically uncorrectable problem affecting your abdominal wall or cavity or uncorrectable problem that increases risk of abdominal infections • if you have documented loss of peritoneal function due to severe peritoneal sc 完全なドキュメントを読む
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT EXTRANEAL Solution for peritoneal dialysis. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION A sterile peritoneal dialysis fluid containing Icodextrin at a concentration of 7.5% w/v in an electrolyte solution. Theoretical osmolarity: 284 (milliosmoles per litre) Theoretical osmolality: 301 (milliosmoles per kg) pH = 5 to 6 For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for peritoneal dialysis. Extraneal is a sterile, clear, colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Extraneal is recommended as a once daily replacement for a single glucose exchange as part of a continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) regimen for the treatment of chronic renal failure, particularly for patients who have lost ultrafiltration on glucose solutions, because it can extend time on CAPD therapy in such patients. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology: Extraneal is recommended for use during the longest dwell period, i.e. in CAPD usually overnight and in APD for the long daytime dwell. The mode of therapy, frequency of treatment, exchange volume, duration of dwell and length of dialysis should be initiated and supervised by the physician. _Adults_ Icodextrin 75 g/L Sodium Chloride 5.4 g/L Sodium S-Lactate 4.5 g/L Calcium Chloride 0.257 g/L Magnesium Chloride 0.051 g/L Sodium 133 mmol/L Calcium 1.75 mmol/L Magnesium 0.25 mmol/L Chloride 96 mmol/L Lactate 40 mmol/L Electrolyte solution content per 1000 ml: H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _ 完全なドキュメントを読む